World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
106
Citations
84264
World Ranking
6351
National Ranking
3390

Overview

Gary M. Clark is affiliated with The University of Texas Health Science Center at San Antonio in the United States. Their research contributions primarily focus on Medicine, including subfields such as Pediatrics, Perinatology and Child Health, Clinical Psychology, Molecular Biology, Electrical and Electronic Engineering, and Surgery.

The main topics covered in Clark's work include:

  • Psychedelics and Drug Studies
  • Coenzyme Q10 studies and effects
  • Advanced battery technologies research
  • Pharmacological Effects and Toxicity Studies
  • Anesthesia and Pain Management
  • Childhood Cancer Survivors' Quality of Life

Clark has published in multiple venues, most frequently in:

  • Evidence-Based Practice
  • Journal of Jungian Scholarly Studies

Their recent papers include:

  • Review of The Path of the Serpent, Volume 1: Psychedelics and the Neuropsychology of Gnosis by Hereward Tilton, 2022, Journal of Jungian Scholarly Studies
  • Does coenzyme Q10 enzyme relieve symptoms in patients with heart failure?, 2021, Evidence-Based Practice
  • Which medication is most effective for treatment of PTSD?, 2023, Evidence-Based Practice

Frequent co-authors collaborating with Clark include:

  • Molly Chandler
  • Marco Jose Dela Cruz
  • Christopher Taylor
  • CPT Richard Kolek
  • Chuah-Chih Yang

Best Publications

  • Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

    Dennis J. Slamon;Gary M. Clark;Steven G. Wong;Wendy J. Levin

  • Erlotinib in previously treated non-small-cell lung cancer.

    Frances A. Shepherd;José Rodrigues Pereira;Tudor Ciuleanu;Eng Huat Tan

  • Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

    Malcolm J. Moore;David Goldstein;John Hamm;Arie Figer

  • PROGNOSTIC AND PREDICTIVE FACTORS IN BREAST CANCER BY IMMUNOHISTOCHEMICAL ANALYSIS

    D.C. Allred;Jennet Harvey;M. Berardo;G.M. Clark

  • Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer

    Jennet M. Harvey;Gary M. Clark;C. Kent Osborne;D. Craig Allred

  • Revision of the American Joint Committee on Cancer Staging System for Breast Cancer

    S. Eva Singletary;Craig Allred;Pandora Ashley;Lawrence W. Bassett

  • Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.

    Fitzgibbons Pl;Page Dl;Weaver D;Thor Ad

  • Determinants of Tumor Response and Survival With Erlotinib in Patients With Non—Small-Cell Lung Cancer

    Román Pérez-Soler;Abraham Chachoua;Lisa A. Hammond;Eric K. Rowinsky

  • Prognostic Factors in Breast Cancer

    Patrick L. Fitzgibbons;Patrick L. Fitzgibbons;David L. Page;Donald Weaver;Ann D. Thor

  • Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome

    Grazia Arpino;Valerie J Bardou;Gary M Clark;Richard M Elledge

  • Role of the Estrogen Receptor Coactivator AIB1 (SRC-3) and HER-2/neu in Tamoxifen Resistance in Breast Cancer

    C. Kent Osborne;Valerie Bardou;Torsten A. Hopp;Gary C. Chamness

  • Progesterone Receptor Status Significantly Improves Outcome Prediction Over Estrogen Receptor Status Alone for Adjuvant Endocrine Therapy in Two Large Breast Cancer Databases

    Valerie Jeanne Bardou;Grazia Arpino;Richard M. Elledge;C. Kent Osborne

  • Association of p53 Protein Expression With Tumor Cell Proliferation Rate and Clinical Outcome in Node-Negative Breast Cancer

    D. C. Allred;G. M. Clark;R. Elledge;S. A. W. Fuqua

  • Tumor Characteristics and Clinical Outcome of Elderly Women With Breast Cancer

    Sami G. Diab;Richard M. Elledge;Gary M. Clark

  • HER-2/neu oncogene protein and prognosis in breast cancer.

    Atul K. Tandon;Gary M. Clark;Gary C. Chamness;Axel Ullrich

  • Reporting recommendations for tumor marker prognostic studies.

    Lisa M. McShane;Douglas G. Altman;Willi Sauerbrei;Sheila E. Taube

  • Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry.

    Gary M. Clark;Lynn G. Dressler;Marilyn A. Owens;George Pounds

  • Cathepsin D and prognosis in breast cancer.

    Atul K. Tandon;Gary M. Clark;Gary C. Chamness;John M. Chirgwin

  • HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma.

    D C Allred;G M Clark;A K Tandon;R Molina

  • Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States.

    Richard M. Elledge;Gary M. Clark;Gary C. Chamness;C. Kent Osborne

Frequent Co-Authors

William L. McGuire
William L. McGuire The University of Texas Health Science Center at San Antonio
Daniel D. Von Hoff
Daniel D. Von Hoff Translational Genomics Research Institute
C. Kent Osborne
C. Kent Osborne Baylor College of Medicine
D. Craig Allred
D. Craig Allred The University of Texas Health Science Center at San Antonio
Susan G. Hilsenbeck
Susan G. Hilsenbeck Baylor College of Medicine
Suzanne A. W. Fuqua
Suzanne A. W. Fuqua Baylor College of Medicine
Eleftherios P. Diamandis
Eleftherios P. Diamandis Mount Sinai Hospital
Douglas G. Altman
Douglas G. Altman University of Oxford
Nils Brünner
Nils Brünner University of Copenhagen
Carlos L. Arteaga
Carlos L. Arteaga The University of Texas Southwestern Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online health degrees can open diverse career paths beyond traditional medicine. Prospective students often consider roles in healthcare administration or pharmacy, as these fields offer excellent opportunities for advancement and leadership.

A key concern for many students is the cost of education. If you're interested in administrative roles, it's helpful to compare healthcare administration degree cost to find affordable bachelor’s programs. For advanced credentials, options such as the cheapest master's in healthcare administration can lead to higher-level positions without overwhelming student debt.

Medical professionals looking to progress in clinical practice can also benefit from cheap dnp online programs, offering flexibility and convenience for working nurses aiming for leadership or educational roles. Similarly, those interested in pharmacy can explore accredited online pharmacy programs to advance their careers.

No matter your career goals, understanding online degree options and their associated costs is essential for planning a successful and sustainable pathway in healthcare.

Best Scientists Citing Gary M. Clark

Trending Scientists

Recently Published Articles